Dr Jeffrey Todd Schiff, MD - Medicare Urology in Garden City, NY

Dr Jeffrey Todd Schiff, MD is a medicare enrolled "Urology" physician in Garden City, New York. He went to Tufts University School Of Medicine and graduated in 2006 and has 18 years of diverse experience with area of expertise as Urology. He is a member of the group practice New York University and his current practice location is 1300 Franklin Ave, Suite Ml-6, Garden City, New York. You can reach out to his office (for appointments etc.) via phone at (516) 535-1900.

Dr Jeffrey Todd Schiff is licensed to practice in New York (license number 60-245572) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1568668937.

Contact Information

Dr Jeffrey Todd Schiff, MD
1300 Franklin Ave, Suite Ml-6,
Garden City, NY 11530-1886
(516) 535-1900
(516) 535-1905



Physician's Profile

Full NameDr Jeffrey Todd Schiff
GenderMale
SpecialityUrology
Experience18 Years
Location1300 Franklin Ave, Garden City, New York
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Jeffrey Todd Schiff attended and graduated from Tufts University School Of Medicine in 2006
  NPI Data:
  • NPI Number: 1568668937
  • Provider Enumeration Date: 06/22/2007
  • Last Update Date: 09/12/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 4082883533
  • Enrollment ID: I20110818000007

Medical Identifiers

Medical identifiers for Dr Jeffrey Todd Schiff such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1568668937NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 60-245572 (New York)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Nyu Langone Health Home CareMineola, NYHome health agency
New York University Langone Medical CenterNew york, NYHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
New York University13552324224431

News Archive

Study examines unnecessary medicine use in patients with advanced lung cancer

Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens.

Detrimental impact of iron deficiency made aware by Vifor Pharma at a series of events

The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.

Alternaria fungus produces more spores with increase in CO2 levels and makes life miserable for allergy, asthma sufferers

A new study of the relationship between carbon dioxide levels and plant growth suggests for the first time that not only do plants grow bigger and produce more pollen when exposed to higher levels of the greenhouse gas, CO2, but the common, allergen-producing fungus Alternaria alternate produces three times more spores when feeding on those enriched plants. The spores disperse on the wind, making allergies and asthma symptoms worse.

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Jeffrey Todd Schiff allows following entities to bill medicare on his behalf.
Entity NameState Of New York Comptrollers Office
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1316960289
PECOS PAC ID: 0840101770
Enrollment ID: O20071024000040

News Archive

Study examines unnecessary medicine use in patients with advanced lung cancer

Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens.

Detrimental impact of iron deficiency made aware by Vifor Pharma at a series of events

The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.

Alternaria fungus produces more spores with increase in CO2 levels and makes life miserable for allergy, asthma sufferers

A new study of the relationship between carbon dioxide levels and plant growth suggests for the first time that not only do plants grow bigger and produce more pollen when exposed to higher levels of the greenhouse gas, CO2, but the common, allergen-producing fungus Alternaria alternate produces three times more spores when feeding on those enriched plants. The spores disperse on the wind, making allergies and asthma symptoms worse.

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

Read more Medical News

› Verified 5 days ago

Entity NameNew York University
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285826438
PECOS PAC ID: 1355232422
Enrollment ID: O20081202000185

News Archive

Study examines unnecessary medicine use in patients with advanced lung cancer

Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens.

Detrimental impact of iron deficiency made aware by Vifor Pharma at a series of events

The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.

Alternaria fungus produces more spores with increase in CO2 levels and makes life miserable for allergy, asthma sufferers

A new study of the relationship between carbon dioxide levels and plant growth suggests for the first time that not only do plants grow bigger and produce more pollen when exposed to higher levels of the greenhouse gas, CO2, but the common, allergen-producing fungus Alternaria alternate produces three times more spores when feeding on those enriched plants. The spores disperse on the wind, making allergies and asthma symptoms worse.

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

Read more Medical News

› Verified 5 days ago

Entity NameNew York University
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285826438
PECOS PAC ID: 1355232422
Enrollment ID: O20090822000026

News Archive

Study examines unnecessary medicine use in patients with advanced lung cancer

Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens.

Detrimental impact of iron deficiency made aware by Vifor Pharma at a series of events

The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.

Alternaria fungus produces more spores with increase in CO2 levels and makes life miserable for allergy, asthma sufferers

A new study of the relationship between carbon dioxide levels and plant growth suggests for the first time that not only do plants grow bigger and produce more pollen when exposed to higher levels of the greenhouse gas, CO2, but the common, allergen-producing fungus Alternaria alternate produces three times more spores when feeding on those enriched plants. The spores disperse on the wind, making allergies and asthma symptoms worse.

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

Read more Medical News

› Verified 5 days ago

Entity NameWinthrop Community Medical Affiliates Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457873077
PECOS PAC ID: 5698092385
Enrollment ID: O20150317001669

News Archive

Study examines unnecessary medicine use in patients with advanced lung cancer

Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens.

Detrimental impact of iron deficiency made aware by Vifor Pharma at a series of events

The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.

Alternaria fungus produces more spores with increase in CO2 levels and makes life miserable for allergy, asthma sufferers

A new study of the relationship between carbon dioxide levels and plant growth suggests for the first time that not only do plants grow bigger and produce more pollen when exposed to higher levels of the greenhouse gas, CO2, but the common, allergen-producing fungus Alternaria alternate produces three times more spores when feeding on those enriched plants. The spores disperse on the wind, making allergies and asthma symptoms worse.

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jeffrey Todd Schiff is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Jeffrey Todd Schiff, MD
1300 Franklin Ave, Suite Ml-6,
Garden City, NY 11530-1886

Ph: (516) 535-1900
Dr Jeffrey Todd Schiff, MD
1300 Franklin Ave, Suite Ml-6,
Garden City, NY 11530-1886

Ph: (516) 535-1900

News Archive

Study examines unnecessary medicine use in patients with advanced lung cancer

Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens.

Detrimental impact of iron deficiency made aware by Vifor Pharma at a series of events

The 12th ECCO Congress that took place in Barcelona, Spain, from 15 to 18 February 2017, was an excellent opportunity for Vifor Pharma to continue its support of healthcare efforts and to highlight the detrimental impact of iron deficiency, a particularly common condition in people with certain chronic diseases such as inflammatory bowel disease (IBD).

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.

Alternaria fungus produces more spores with increase in CO2 levels and makes life miserable for allergy, asthma sufferers

A new study of the relationship between carbon dioxide levels and plant growth suggests for the first time that not only do plants grow bigger and produce more pollen when exposed to higher levels of the greenhouse gas, CO2, but the common, allergen-producing fungus Alternaria alternate produces three times more spores when feeding on those enriched plants. The spores disperse on the wind, making allergies and asthma symptoms worse.

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

Read more News

› Verified 5 days ago


Urology Doctors in Garden City, NY

Jeffrey H Lumerman, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 601 Franklin Ave, Suite 300, Garden City, NY 11530
Phone: 516-742-3200    Fax: 516-746-5847
Dr. Omid Rofeim, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 233 7th St, Suite 203, Garden City, NY 11530
Phone: 516-294-7666    Fax: 516-294-7672
Barry R Shepard, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 601 Franklin Ave, Suite 300, Garden City, NY 11530
Phone: 516-742-3200    Fax: 516-746-5847
Brett C Mellinger, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 100 Garden City Plaza, Suite 102, Garden City, NY 11530
Phone: 516-873-5353    Fax: 516-873-8850
Igor Inoyatov, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 1300 Franklin Ave Ste Ml6, Garden City, NY 11530
Phone: 516-535-1905    
Mitchell D Efros, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1305 Franklin Ave, Garden City, NY 11530
Phone: 516-742-3200    Fax: 516-746-5847
Anthony M Bruno, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 1305 Franklin Ave, Suite 100, Garden City, NY 11530
Phone: 516-746-5550    Fax: 516-746-9641

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.